Abstract
Recent work aimed at the introduction of natural and synthetic cannabinoids as drugs is reviewed. Delta1-Tetrahydrocannabinol (delta1-THC) is mainly investigated as a potential drug against glaucoma and asthma, and as an antiemetic agent in cancer chemotherapy. Cannabidiol is being tried in the clinic against epilepsy and as a hypnotic. Numerous synthetic cannabinoids are currently being investigated as analgetics and as sedative-relaxants.
Publication types
- Historical Article
- Review
MeSH terms
- Analgesics
- Anti-Inflammatory Agents
- Antiemetics
- Asthma / drug therapy
- Cannabidiol / therapeutic use
- Cannabinoids / therapeutic use
- Cannabis*
- Dronabinol / therapeutic use
- Dronabinol / toxicity
- Epilepsy / drug therapy
- Glaucoma / drug therapy
- History, Ancient
- History, Medieval
- History, Modern 1601-
- Humans
- Hypertension / drug therapy
- Medicine, Arabic
- Medicine, East Asian Traditional
- Phytotherapy
- Sleep Initiation and Maintenance Disorders / drug therapy
- Structure-Activity Relationship
Substances
- Analgesics
- Anti-Inflammatory Agents
- Antiemetics
- Cannabinoids
- Cannabidiol
- Dronabinol